The 10th Santorini conference: Systems medicine, personalised health and therapy. "The odyssey from hope to practice: Patient first. ", Santorini, Greece, 23-26 May 2022.
作者信息
Visvikis-Siest Sophie, Stathopoulou Maria G, Sunder-Plassmann Raute, Alizadeh Behrooz Z, Barouki Robert, Chatzaki Ekaterina, Dagher Georges, Dedoussis George, Deloukas Panagiotis, Haliassos Alexander, Hiegel Brigitte Boisson, Manolopoulos Vangelis, Masson Christine, Paré Guillaume, Paulmichl Markus, Petrelis Alexandros M, Sipeky Csilla, Süsleyici Belgin, Weryha Georges, Chenchik Alex, Diehl Paul, Everts Robin E, Haushofer Alexander, Lamont John, Mercado Ruth, Meyer Heiko, Munoz-Galeano Herna, Murray Helena, Nhat Ferrier, Nofziger Charity, Schnitzel Wolfgang, Kanoni Stavroula
机构信息
EA_1122 IGE-PCV, Université de Lorraine, Nancy, France.
Team 10: Control of Gene Expression, INSERM U, Centre Méditerranéen de Médecine Moléculaire C3M, Nice, France.
出版信息
Front Genet. 2023 Mar 9;14:1171131. doi: 10.3389/fgene.2023.1171131. eCollection 2023.
Abstract
摘要
相似文献
1
The 10th Santorini conference: Systems medicine, personalised health and therapy. "The odyssey from hope to practice: Patient first. ", Santorini, Greece, 23-26 May 2022.
Front Genet. 2023 Mar 9;14:1171131. doi: 10.3389/fgene.2023.1171131. eCollection 2023.
2
The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. "The Odyssey from Hope to Practice", Santorini, Greece, 30 September⁻3 October 2018.
J Pers Med. 2018 Dec 12;8(4):43. doi: 10.3390/jpm8040043.
3
Personalised Medicine: The Odyssey from Hope to Practice.
J Pers Med. 2018 Sep 21;8(4):31. doi: 10.3390/jpm8040031.
4
8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016.
Drug Metab Pers Ther. 2017 May 24;32(2):119-127. doi: 10.1515/dmpt-2017-0011.
5
Pharmacogenomics and personalized medicine in clinical practice.
Pharmacogenomics. 2011 May;12(5):597-610. doi: 10.2217/pgs.11.14.
6
Systems medicine, personalized health and therapy.
Pharmacogenomics. 2015;16(14):1527-39. doi: 10.2217/pgs.15.103. Epub 2015 Sep 24.
7
Functional genomics towards personalized healthcare and systems medicine.
Per Med. 2011 May;8(3):227-242. doi: 10.2217/pme.10.89.
8
From systems biology and functional genomics to personalized health. 5th Biologie Prospective Santorini Conference, Island of Santorini, Greece, September 30-October 2, 2010.
Drug Metabol Drug Interact. 2011;26(1):41-2. doi: 10.1515/DMDI.2011.104. Epub 2011 Mar 16.
9
From genetic variations to risk prediction and pharmacogenomics. Proceedings of the First Santorini Conference. Santorini, Greece. September 25-28. 2002.
Clin Chem Lab Med. 2003 Apr;41(4):397-614. doi: 10.1515/CCLM.2003.062.
10
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education.
Pharmacogenomics J. 2005;5(4):221-5. doi: 10.1038/sj.tpj.6500312.
本文引用的文献
1
The power of genetic diversity in genome-wide association studies of lipids.
Nature. 2021 Dec;600(7890):675-679. doi: 10.1038/s41586-021-04064-3. Epub 2021 Dec 9.
2
Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia.
Front Pharmacol. 2021 Jun 28;12:696960. doi: 10.3389/fphar.2021.696960. eCollection 2021.
3
Liquid Biopsy: From Discovery to Clinical Application.
Cancer Discov. 2021 Apr;11(4):858-873. doi: 10.1158/2159-8290.CD-20-1311.
4
Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial.
Mol Nutr Food Res. 2021 May;65(10):e2001178. doi: 10.1002/mnfr.202001178. Epub 2021 Apr 16.
5
Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones.
Mol Cancer. 2021 Feb 8;20(1):30. doi: 10.1186/s12943-021-01326-6.
6
Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay.
Cells. 2020 Oct 22;9(11):2337. doi: 10.3390/cells9112337.
7
International liquid biopsy standardization alliance white paper.
Crit Rev Oncol Hematol. 2020 Dec;156:103112. doi: 10.1016/j.critrevonc.2020.103112. Epub 2020 Sep 30.
8
High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
Cells. 2020 Sep 20;9(9):2129. doi: 10.3390/cells9092129.
9
Pre-analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients.
Mol Oncol. 2020 May;14(5):1001-1015. doi: 10.1002/1878-0261.12669. Epub 2020 Apr 4.
10
The future of liquid biopsy.
Nature. 2020 Mar;579(7800):S9. doi: 10.1038/d41586-020-00844-5.
Zotero 插件